Treg Cells Show Promise as Immunotherapy for Crohn ' s Disease Treg Cells Show Promise as Immunotherapy for Crohn ' s Disease
Crohn ' s disease (CD) symptoms may be reduced if an agonist of the retinoic acid receptor alpha (RARA) can be used to traffic T-regulatory (Treg) cells to inflamed intestinal tissues, researchers suggest.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news
More News: Allergy | Allergy & Immunology | Crohn's Disease | Gastroenterology | Immunotherapy | Inflammatory Bowel Disease